Ulead Medicine Technology

Ulead Medicine is a clinical-stage biopharmaceutical company based in Shanghai, China, dedicated to the discovery and development of novel small molecule drugs. The company leverages its expertise in medicinal chemistry and structure-based drug design to target immunology, oncology, and metabolic disorders. Its lead program, UL-001, is a highly selective Tyrosine kinase 2 (TYK2) inhibitor designed to treat various autoimmune diseases, including psoriasis and atopic dermatitis. Ulead Medicine focuses on developing best-in-class therapies that offer superior selectivity and safety compared to existing treatments. The company was founded by industry veterans with extensive experience in global pharmaceutical R&D.